Tumor immune microenvironment and nivolumab efficacy in EGFR mutation-positive non-small-cell lung cancer based on T790M status after disease progression during EGFR-TKI treatment.
| Image |  |
|---|---|
| Description | scientific article published on 12 April 2017 |
| Author/s |
author: Kazuya Tanimura |
| Publication date | July 1, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |